1.Skin Rash.
Journal of the Korean Medical Association 1999;42(7):700-703
No abstract available.
Exanthema*
;
Skin*
2.Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy.
Chee Won OH ; Jimi YOON ; Chi Yeon KIM
Annals of Dermatology 2012;24(3):360-362
No abstract available.
Bacillus
;
Exanthema
;
Immunotherapy
;
Pityriasis
3.Skin Rashes in Children.
Journal of the Korean Pediatric Society 1998;41(4):431-431
No abstract available.
Child*
;
Exanthema*
;
Humans
;
Skin*
4.Morbilliform rashes as sole manifestation of COVID-19
The Filipino Family Physician 2021;59(1):124-126
Coronavirus Disease 2019 (Covid-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is recognized as a worldwide public health crisis. It has rapidly spread from Wuhan City in China after an outbreak of flu-like illness. Respiratory symptoms remain the most common manifestation of Covid-19. However, dermatologic manifestations have been observed in patients with COVID-19 infection. Kulkharni, et al. published a case report of morbilliform rashes as a probable herald of Covid-19 being its initial and only manifestation of COVID-19.1 This is a case of a 45-year-old female who presented with worsening morbilliform rashes on both upper extremities and was initially diagnosed with allergic contact dermatitis. She had no respiratory symptoms and was eventually diagnosed with Covid-19 in a routine Reverse Transcription Polymerase Chain Reaction test (RT-PCR). She was subsequently admitted for treatment and recovered after 2 weeks of hospital stay.
Covid-19
;
Exanthema
5.Dermatological Side Effects of Anti-tumor Necrosis Factor Alpha Therapy.
Journal of Rheumatic Diseases 2014;21(1):9-19
As anti-tumor necrosis factor alpha (anti-TNFalpha) agents are progressively being used in various medical conditions, dermatological adverse events have been encountered more frequently. To understand such dermatological conditions that have been documented while undergoing anti-TNF therapy, we reviewed relevant literature, including case reports and case series. Reported dermatological conditions included infusion and injection site reaction, cutaneous infection, psoriasiform eruption, dermatitis, allergic rash, lupus-like lesion, vasculitis, lichenoid reaction, granulomatous reaction, hair loss, cutaneous infection, and cutaneous neoplasm. These events had varying strengths of causal association and severity therefore, drug discontinuation may or may not be required.
Dermatitis
;
Exanthema
;
Hair
;
Necrosis*
;
Vasculitis
6.Reevaluation of the importance of finding rash, lymphadenitis and eschars for the early clinical diagnosis of Tsutsugamushi disease.
Kang Su YI ; Sung Kun YOU ; Wan KO ; Won Young LEE ; Chin Ki PAI ; Ki Il KIM ; Yunsop CHONG
Korean Journal of Infectious Diseases 1991;23(3):163-169
No abstract available.
Diagnosis*
;
Exanthema*
;
Lymphadenitis*
;
Scrub Typhus*
7.Symmetrical Flexural and Intertriginous Exanthema: A Rare Manifestation Associated with COVID-19 Infection
Jin Yi Goh ; Huang Hin Chin ; Pek Woon Chin ; Masliza Zaid
Malaysian Journal of Dermatology 2021;46(June 2021):55-57
Summary
Cutaneous manifestations of Coronavirus disease (COVID-19) are variable. We present a case of non-drug related symmetrical flexural and intertriginous exanthema in a patient with COVID-19 infection. A 58-year-old Chinese male who was diagnosed to have COVID-19 infection, developed maculopapular erythematous rashes at bilateral axillary and inguinal folds on the fourth day of illness. He was treated symptomatically with anti-histamine and topical corticosteroid. The skin condition improved and he was discharged well on tenth day of illness. Although symmetrical flexural intertriginous exanthema isclassically caused by drug reaction, this case demonstrated the possibility of the rash being directly associated with COVID-19 infection. More cohorts should be evaluated to fully describe the full spectrum of dermatological manifestation in COVID-19.
Exanthema
;
COVID-19
;
Skin Manifestations
8.Predicting Factors of Roseola Infantum Infected with Human Herpesvirus 6 from Urinary Tract Infection.
Hong Ryul KO ; Son Moon SHIN ; Sung Won PARK
Childhood Kidney Diseases 2016;20(2):69-73
PURPOSE: The aim of this study was to compare the clinical and laboratory features of infants with roseola infantum due to human herpesvirus 6 (HHV6) infection and those with urinary tract infection (UTI). METHODS: We retrospectively reviewed the medical records of children who were hospitalized at Cheil General Hospital and Women's Health Care Center, College of Medicine, Dankook University, and diagnosed as having HHV6 infection or UTI. RESULTS: Among the infants admitted between September 2014 and May 2016, 92 (male, 45 and female, 47) were included in the study and divided into a HHV6 infection group (n=50) and a UTI group (n=42). The relative risk of UTI compared with that of HHV6 infection increased with pyuria (P<0.001), increased with leukocytosis (mean white blood cell [WBC] count, 15,048±5,756/mm³ vs 87,916±54,056/mm³; P<0.001), increased with C-reactive protein (CRP) level (4.89±4.85 mg/dL vs 1.04±1.76 mg/dL; P<0.001), and younger age (6.3±3.2 months vs 18.3±12.6 months; P<0.001). The relative risk of HHV6 infection compared with that of UTI increased with fever duration (4.3±1.7 days vs 2.8±1.7 days; P<0.001) and decreased with platelet (PLT) count (373±94×10³/mm³ vs 229±90×10³/mm³; P<0.001). No significant differences were found between the HHV6 groups according to the presence or absence of pyuria. CONCLUSION: Pyuria, age, fever duration, WBC count, CRP level, and PLT count were the differentiating factors of HHV6 infection from UTI. However, sterile pyuria can occur in children with HHV6 infection. In the presence of pyuria, CRP level and PLT count were the strong predictors of UTI compared with HHV6.
Blood Platelets
;
C-Reactive Protein
;
Child
;
Exanthema Subitum*
;
Female
;
Fever
;
Herpesvirus 6, Human*
;
Hospitals, General
;
Humans*
;
Infant
;
Leukocytes
;
Leukocytosis
;
Medical Records
;
Pyuria
;
Retrospective Studies
;
Urinary Tract Infections*
;
Urinary Tract*
;
Women's Health
9.Prasugrel-Induced Hypersensitivity Skin Reaction.
Soo Han KIM ; Sang Don PARK ; Yong Soo BAEK ; Seon Young LEE ; Sung Hee SHIN ; Sung Il WOO ; Dae Hyeok KIM ; Jun KWAN
Korean Circulation Journal 2014;44(5):355-357
We report a case of hypersensitivity skin reaction to prasugrel. The patient exhibited a generalized skin rash after treatment with prasugrel, which was resolved after discontinuation of prasugrel and substitution to clopidogrel. Clopidogrel was successfully administered as an alternative to prasugrel without any signs of further hypersensitivity.
Exanthema
;
Humans
;
Hypersensitivity*
;
Skin*
;
Prasugrel Hydrochloride
10.A case of Methimazole-Induced Cholestatic Jaundice With Agranulocytosis.
Sang Gu KANG ; Jong Oh BAE ; Eun Young LEE ; Seong Min LIM ; Sang Kun CHO ; Ji Hye KIM ; Sun Kyung SONG
Journal of Korean Society of Endocrinology 2005;20(5):519-523
Methimazole is a widely used and generally well-tolerated antithyroid agent. Adverse reactions occur in 1~5% of patients taking methimazole medication, but these are most commonly transient, benign leukopenia and a skin rash. Severe cholestatic jaundice, combined with agranulocytosis, has been known as a rare complication. Herein, a case of methimazole induced cholestatic jaundice, with agranulocytosis, is reported.
Agranulocytosis*
;
Exanthema
;
Humans
;
Jaundice, Obstructive*
;
Leukopenia
;
Methimazole